Here's why severe asthma market is growing | Healthcare Asia Magazine
, APAC
Photo by Sincerely Media via Unsplash

Here's why severe asthma market is growing

Over 40 companies are working on more than 50 therapies for severe asthma.

The severe asthma market is growing due to a rising number of cases, particularly in urban areas and advancements in treatment, according to DelveInsight's report.

New biologic drugs targeting IgE and cytokine modulators are improving treatment options, while personalised medicine is enhancing both effectiveness and patient adherence.

Government initiatives and increased awareness are also expanding access to care, and advances in inhaler technology are further boosting medication adherence.

Moreover, collaboration in research and development is also driving innovation in asthma treatments.

The report also highlights a strong pipeline, with over 40 companies working on more than 50 therapies for severe asthma. Leading companies in this space include Kinaset Therapeutics, Bio-Thera Solutions, GlaxoSmithKline, AstraZeneca, Teva, and Sanofi, amongst others. These companies are developing new drugs to improve treatment outcomes.

Promising therapies in clinical trials include KN-002, BAT2606, CM326, Masitinib, GSK3511294, FB 704A, and others.

Severe asthma, which is characterized by persistent symptoms that don't respond well to standard treatment, can significantly impact quality of life and often leads to frequent hospitalizations. The growing pipeline of treatments offers hope for better management of the condition in the future.
 

Join Healthcare Asia Magazine community
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

Exclusives

NUHCS to start using breakthrough drug for rare lung condition
Winrevair, which treats hypertension from constricted lung arteries, costs  $3,700-$6,730
Healthcare
Singapore’s aged care homes fall short
Their services are routinary and not personalised mainly due to resource constraints.
Healthcare
Electronic health records with AI show promise
They are also at risk from backdoor attacks, data poisoning and unauthorised access.